{"id":"https://openalex.org/W3193665070","doi":"https://doi.org/10.5530/srp.2020.1.74","title":"Analysis of Current Ratio, Net Profit Margin, and Good Corporate Governance against Company Value","display_name":"Analysis of Current Ratio, Net Profit Margin, and Good Corporate Governance against Company Value","publication_year":2020,"publication_date":"2020-01-01","ids":{"openalex":"https://openalex.org/W3193665070","doi":"https://doi.org/10.5530/srp.2020.1.74","mag":"3193665070"},"language":"en","primary_location":{"id":"mag:3193665070","doi":"https://doi.org/10.5530/srp.2020.1.74","is_oa":false,"landing_page_url":"https://www.sysrevpharm.org/articles/analysis-of-current-ratio-net-profit-margin-and-good-corporate-governance-against-company-value.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S3096383","display_name":"Systematic Reviews in Pharmacy","issn_l":"0975-8453","issn":["0975-8453","0976-2779"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20"],"host_organization":"https://openalex.org/P4310320448","host_organization_name":"Medknow","host_organization_lineage":["https://openalex.org/P4310320448","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Medknow","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Systematic Reviews in Pharmacy","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057840949","display_name":"Dedi Mulyadi","orcid":"https://orcid.org/0000-0001-9734-2784","observed_orcids":["https://orcid.org/0000-0001-9734-2784"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dedi Mulyadi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9734-2784","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034226156","display_name":"Sihabudin Sihabudin","orcid":"https://orcid.org/0009-0003-0770-3809","observed_orcids":["https://orcid.org/0009-0003-0770-3809"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sihabudin Sihabudin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5005581855","display_name":"Obsatar Sinaga","orcid":"https://orcid.org/0000-0002-7829-3902","observed_orcids":["https://orcid.org/0000-0002-7829-3902"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Obsatar Sinaga","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7829-3902","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":13.6639,"has_fulltext":false,"cited_by_count":49,"citation_normalized_percentile":{"value":0.98850696,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"11","issue":"1","first_page":"588","last_page":"600"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12123","display_name":"Financial Analysis and Corporate Governance","score":0.79830002784729,"subfield":{"id":"https://openalex.org/subfields/1402","display_name":"Accounting"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12123","display_name":"Financial Analysis and Corporate Governance","score":0.79830002784729,"subfield":{"id":"https://openalex.org/subfields/1402","display_name":"Accounting"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13957","display_name":"Corporate Governance and Financial Management","score":0.17219999432563782,"subfield":{"id":"https://openalex.org/subfields/1408","display_name":"Strategy and Management"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12675","display_name":"Financial Reporting and Valuation Research","score":0.010400000028312206,"subfield":{"id":"https://openalex.org/subfields/1408","display_name":"Strategy and Management"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/current-ratio","display_name":"current ratio","score":0.9589999914169312},{"id":"https://openalex.org/keywords/net-profit-margin","display_name":"net profit margin","score":1.0},{"id":"https://openalex.org/keywords/good-corporate-governance","display_name":"good corporate governance","score":0.9380000233650208},{"id":"https://openalex.org/keywords/firm-value","display_name":"firm value","score":0.9129999876022339},{"id":"https://openalex.org/keywords/liquidity","display_name":"liquidity","score":0.4880000054836273},{"id":"https://openalex.org/keywords/profitability","display_name":"profitability","score":0.9819999933242798},{"id":"https://openalex.org/keywords/infrastructure-companies","display_name":"infrastructure companies","score":0.6859999895095825},{"id":"https://openalex.org/keywords/transport-companies","display_name":"transport companies","score":0.9940000176429749},{"id":"https://openalex.org/keywords/indonesia-stock-exchange-listed-companies","display_name":"Indonesia Stock Exchange listed companies","score":0.8560000061988831},{"id":"https://openalex.org/keywords/financial-ratios","display_name":"financial ratios","score":0.6660000085830688},{"id":"https://openalex.org/keywords/corporate-governance-quality","display_name":"corporate governance quality","score":0.38199999928474426}],"concepts":[{"id":"https://openalex.org/C189560676","wikidata":"https://www.wikidata.org/wiki/Q1187906","display_name":"Profit margin","level":2,"score":0.751296877861023},{"id":"https://openalex.org/C39389867","wikidata":"https://www.wikidata.org/wiki/Q380767","display_name":"Corporate governance","level":2,"score":0.7497552037239075},{"id":"https://openalex.org/C200870193","wikidata":"https://www.wikidata.org/wiki/Q11691","display_name":"Stock exchange","level":2,"score":0.7227472066879272},{"id":"https://openalex.org/C52272595","wikidata":"https://www.wikidata.org/wiki/Q2210989","display_name":"Current ratio","level":3,"score":0.6916224360466003},{"id":"https://openalex.org/C100716732","wikidata":"https://www.wikidata.org/wiki/Q570938","display_name":"Net profit","level":3,"score":0.62269127368927},{"id":"https://openalex.org/C74370782","wikidata":"https://www.wikidata.org/wiki/Q722249","display_name":"Operating margin","level":4,"score":0.6050964593887329},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.5844500064849854},{"id":"https://openalex.org/C181622380","wikidata":"https://www.wikidata.org/wiki/Q26911","display_name":"Profit (economics)","level":2,"score":0.5027649402618408},{"id":"https://openalex.org/C121955636","wikidata":"https://www.wikidata.org/wiki/Q4116214","display_name":"Accounting","level":1,"score":0.43032363057136536},{"id":"https://openalex.org/C25070020","wikidata":"https://www.wikidata.org/wiki/Q426971","display_name":"Economic Value Added","level":3,"score":0.4263285994529724},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.34144502878189087},{"id":"https://openalex.org/C40700","wikidata":"https://www.wikidata.org/wiki/Q1411783","display_name":"Industrial organization","level":1,"score":0.3268396258354187},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.28294920921325684},{"id":"https://openalex.org/C175444787","wikidata":"https://www.wikidata.org/wiki/Q39072","display_name":"Microeconomics","level":1,"score":0.19081929326057434},{"id":"https://openalex.org/C185669311","wikidata":"https://www.wikidata.org/wiki/Q1163221","display_name":"Return on assets","level":3,"score":0.07400193810462952}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3193665070","doi":"https://doi.org/10.5530/srp.2020.1.74","is_oa":false,"landing_page_url":"https://www.sysrevpharm.org/articles/analysis-of-current-ratio-net-profit-margin-and-good-corporate-governance-against-company-value.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S3096383","display_name":"Systematic Reviews in Pharmacy","issn_l":"0975-8453","issn":["0975-8453","0976-2779"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20"],"host_organization":"https://openalex.org/P4310320448","host_organization_name":"Medknow","host_organization_lineage":["https://openalex.org/P4310320448","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Medknow","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Systematic Reviews in Pharmacy","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.7207000255584717,"id":"https://metadata.un.org/sdg/9","display_name":"Industry, innovation and infrastructure"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3014694848","https://openalex.org/W4413898974","https://openalex.org/W3108074716","https://openalex.org/W3190198632","https://openalex.org/W3216389416","https://openalex.org/W3176918183","https://openalex.org/W4413733737","https://openalex.org/W4395101070","https://openalex.org/W7127042845","https://openalex.org/W4404062288"],"abstract_inverted_index":{"The":[0,190,234],"purpose":[1],"of":[2,10,49,71,83,132,187,192,204,218,244,258,265,273,299,323,351,375,404,429,456,487,519],"the":[3,8,33,50,60,72,77,81,106,124,173,185,188,198,202,205,216,219,224,239,242,245,256,259,269],"study":[4,110],"was":[5,111],"to":[6,63,215,289],"analyze":[7],"effect":[9,145,156,167],"Current":[11,84,139,300,324,352,376,405,430,457,488,520],"Ratio,":[12,85,301,325,353,377,406,431,458,489,521],"Net":[13,86,150,302,326,354,378,407,432,459,490,522],"Profit":[14,87,151,303,327,355,379,408,433,460,491,523],"Margin,":[15,88,304,328,356,380,409,434,461,492,524],"and":[16,28,45,59,68,74,89,101,116,179,211,251,279,305,329,357,381,410,435,462,493,525],"Good":[17,90,161,306,330,358,382,411,436,463,494,526],"Corporate":[18,91,94,162,307,331,359,383,412,437,464,495,527],"Governance":[19,92,163,308,332,360,384,413,438,465,496,528],"on":[20,25,32,98,105,113,123,146,157,168],"Company":[21,310,334,362,386,415,440,467,498,530],"Value":[22,95],"(Case":[23,96],"Study":[24,97],"Infrastructure,":[26,99,114],"Utilities,":[27,100,115],"Transportation":[29,102,117],"Companies":[30,103,119],"Listed":[31,104,122],"Indonesia":[34,107,125],"Stock":[35,108,126],"Exchange).\r\nThe":[36,109],"research":[37,42],"method":[38],"used":[39],"in":[40,444,471,502,534],"this":[41,291],"is":[43,62,221,227,261,286],"descriptive":[44],"verification":[46],"methods,":[47],"because":[48],"variables":[51,78,243,272],"that":[52,120,137,197,238,268],"will":[53],"be":[54],"examined":[55],"for":[56],"their":[57],"relationship":[58,270],"aim":[61],"present":[64],"a":[65,129,143],"structured,":[66],"factual,":[67],"accurate":[69],"picture":[70],"facts":[73],"relationships":[75],"between":[76,241,271],"studied,":[79],"namely":[80],"influence":[82,184],"Against":[93],"conducted":[112],"Sector":[118],"are":[121],"Exchange":[127],"with":[128,255,283],"total":[130],"sample":[131],"5":[133],"companies.\r\nThe":[134],"results":[135],"showed":[136],"partially":[138],"Ratio":[140],"(CR)":[141],"had":[142,154,165],"positive":[144,262],"increasing":[147,158,169],"company":[148,159,170,220,260],"value,":[149,160],"Margin":[152],"(NPM)":[153],"an":[155,166],"(GCG)":[164],"value.":[171],"Simultaneously":[172],"current":[174,206,246,274],"ratio,":[175,207,247,275],"net":[176,208,248,276],"profit":[177,209,249,277],"margin,":[178,210,250,278],"good":[180,212,252,280],"corporate":[181,213,253,281],"governance":[182,214,254,282],"significantly":[183],"value":[186,217,257,285],"company.":[189],"coefficient":[191,236],"determination":[193],"(Adjusted":[194],"R2)":[195],"shows":[196,237],"contribution":[199],"given":[200],"by":[201,229],"variable":[203],"96.2%":[222],"while":[223],"remaining":[225],"3.8%":[226],"influenced":[228],"other":[230],"factors":[231],"not":[232],"examined.":[233],"correlation":[235,240],"0.981.":[263],"Correlation":[264],"0.981":[266],"proves":[267],"firm":[284],"very":[287],"strong.\r\n\r\n\r\n\r\n\r\n\t\r\n\t\t\r\n\t\t\tHow":[288],"Cite":[290],"Article\r\n\t\t\r\n\t\t\r\n\t\t\tPubmed":[292],"Style\r\n\t\t\t\r\n\t\t\tDedi":[293,317],"Mulyadi,":[294,318,346,370,398,423,451,482,513],"Sihabudin,":[295,319,347,371,399,424,452,483,514],"Obsatar":[296,320,348,372,400,425,453,484,515],"Sinaga.":[297,321,349,373,426,454,485],"Analysis":[455,486],"against":[309,333,361,385,414,439,466,497,529],"Value.":[468,499],"SRP.":[312,364,388],"2020;":[313,365],"11(1):":[314,366,394],"588-600.":[315,367,395,420,448,475,506,538],"doi:10.5530/srp.2020.1.74\r\n\t\t\t\r\n\t\t\tWeb":[316],"http://www.sysrevpharm.org/?mno=86294":[336],"[Access:":[337],"March":[338,391],"28,":[339,392],"2021].":[340],"doi:10.5530/srp.2020.1.74\r\n\r\n\t\t\t\r\n\t\t\tAMA":[341],"(American":[342,509],"Medical":[343],"Association)":[344,480,511],"Style\r\n\r\n\t\t\tDedi":[345,369,397,422,450,481,512],"doi:10.5530/srp.2020.1.74\r\n\r\n\t\t\t\r\n\t\t\tVancouver/ICMJE":[368],"(2020),":[389,474,505],"[cited":[390],"2021];":[393],"doi:10.5530/srp.2020.1.74\r\n\r\n\t\t\t\r\n\t\t\tHarvard":[396],"Sinaga":[401,516],"(2020)":[402,517],"SRP,":[417],"11":[418,446,473,536],"(1),":[419,447,537],"doi:10.5530/srp.2020.1.74\r\n\r\n\t\t\t\r\n\t\t\tTurabian":[421],"2020.":[427],"Systematic":[442,469,500,532],"Reviews":[443,470,501,533],"Pharmacy,":[445,535],"doi:10.5530/srp.2020.1.74\r\n\r\n\t\t\t\r\n\t\t\tChicago":[449],"Pharmacy":[472,503],"doi:10.5530/srp.2020.1.74\r\n\r\n\t\t\t\r\n\t\t\tMLA":[476],"(The":[477],"Modern":[478],"Language":[479],"11.1":[504],"Print.":[507],"doi:10.5530/srp.2020.1.74\r\n\r\n\t\t\t\r\n\t\t\tAPA":[508],"Psychological":[510],"doi:10.5530/srp.2020.1.74":[539]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":15},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2021-08-30T00:00:00"}